These retrograde target genes, previously referred to as MDS genes, include members of cytochrome P450 monooxygenases, glutathione S-transferases, UDP-glucosyl transferases and transmembrane transporters that have putative functions in detoxification and transport of toxic and/or reactive molecules. This evidence concerns the gene CYP20A1 and myelodysplastic syndrome.